4.7 Article

Characterization of the dynamics of Plasmodium falciparum deoxynucleotide-triphosphate pool in a stage-specific manner

期刊

SCIENTIFIC REPORTS
卷 12, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-022-23807-4

关键词

-

资金

  1. National Research, Development and Innovation Office of Hungary [K119493, K135231, VEKOP-2.3.2-16-2017-00013, NKP-2018-1.2.1-NKP-2018-00005]
  2. New National Excellence Program from the National Research, Development and Innovation Fund, Hungary [TKP2021-EGA-02, uNKP-21-3]
  3. Federation of European Biochemical Societies through a FEBS Short-term Fellowship

向作者/读者索取更多资源

Understanding the molecular background of genomic integrity maintenance is crucial for understanding the rapid adaptation of the malaria parasite, Plasmodium falciparum, to antimalarials. This study focused on the nucleotide pools in different stages of the parasite and found significant differences in the ratio of nucleotides between stages. The findings also revealed the impact of a drug on nucleotide levels that were previously unknown.
Understanding and characterizing the molecular background of the maintenance of genomic integrity might be a major factor in comprehending the exceptional ability of the malaria parasite, Plasmodium falciparum to adapt at a fast pace to antimalarials. A balanced nucleotide pool is an essential factor for high-fidelity replication. The lack of detailed studies on deoxynucleotide-triphosphate (dNTP) pools in various intraerythrocytic stages of Plasmodium falciparum motivated our present study. Here, we focused on the building blocks of DNA and utilized an EvaGreen-based dNTP incorporation assay to successfully measure the temporal dynamics of dNTPs in every intraerythrocytic stage and in drug-treated trophozoites. Our findings show that the ratio of dNTPs in the ring-stage parasites significantly differs from the more mature trophozoite and schizont stages. We were also able to detect dGTP levels that have never been shown before and found it to be the least abundant dNTP in all stages. Treatment with WR99210, a TS-DHFR inhibitor drug, affected not only dTTP, but also dGTP levels, despite its presumed selective action on pyrimidine biosynthesis. Results from our studies might assist in a better understanding of genome integrity mechanisms and may potentially lead to novel drug related aspects involving purine and pyrimidine metabolic targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据